Continuous Positive Airway Pressure
Celebrating World Sleep Day across specialties: OSA ‘touches every organ’
Across the globe, health care professionals are celebrating World Sleep Day, an event created by the World Sleep Society, on March 14.
Treating sleep apnea deemed important by US adults but 31% not receiving treatment
A greater proportion of U.S. adults said treating sleep apnea was “extremely” or “moderately” important vs. “minimally” or “not at all important,” according to survey data from the National Sleep Foundation and Inspire Medical Systems Inc.
CPAP decreases blood pressure in patients with OSA, uncontrolled hypertension
Among patients with moderate to severe obstructive sleep apnea and uncontrolled hypertension, some measures of blood pressure fell significantly with 6-month CPAP use, according to data published in Annals of the American Thoracic Society.
Odds for motor vehicle accidents fall with sleep surgery vs. CPAP in OSA
Among patients with obstructive sleep apnea, those treated with sleep surgery vs. CPAP had decreased odds for motor vehicle accident incidence, according to results published in Otolaryngology-Head and Neck Surgery.
Peer-driven intervention raises CPAP adherence in OSA
Patients with obstructive sleep apnea partaking in a peer-driven intervention vs. receiving usual care and educational materials had improved CPAP adherence, according to study findings.
Mandibular advancement device plus expiratory positive airway pressure favorable in OSA
Patients with mild/moderate obstructive sleep apnea treated with a mandibular advancement device plus expiratory positive airway pressure reported improved sleep quality at 6 months, according to a study poster.
FDA grants de novo clearance to bacterial reduction device for CPAP masks, hoses
The FDA has granted de novo clearance to SoClean 3+, an over-the-counter bacterial reduction device for certain CPAP masks and hoses designed to be used after their recommended cleaning procedures, according to a press release.
Pitolisant safe, lowers daytime sleepiness in OSA over 1 year
Among adults with obstructive sleep apnea, excessive daytime sleepiness decreased with 1 year of pitolisant treatment, according to results published in CHEST.
CPAP lowers vascular inflammation, unstable plaque volume in OSA
Adults with obstructive sleep apnea treated with CPAP for 24 weeks had improved vascular inflammation and lower unstable plaque volume, according to results published in Annals of the American Thoracic Society.
Patients treated with positive airway pressure for OSA report adverse effects, mask issues
Around 20% of patients with obstructive sleep apnea starting positive airway pressure reported dry throat/mouth, waking too early and mask discomfort as bothersome issues of the therapy, according to research presented at SLEEP 2024.